Letter to the Editor Regarding "Intraarterial Dantrolene for Refractory Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage": Is Malignant Hyperthermia a Model for Showing Dantrolene Efficacy in Limiting Brain Damage?

[1]  M. Inan,et al.  Post-Operative Malignant Hyperthermia in a Child after Colon Interposition. , 2015, Turkish journal of anaesthesiology and reanimation.

[2]  A. Wakhloo,et al.  Dantrolene for cerebral vasospasm after subarachnoid haemorrhage: a randomised double blind placebo-controlled safety trial , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  M. Martina,et al.  Temperature-Sensitive Cav1.2 Calcium Channels Support Intrinsic Firing of Pyramidal Neurons and Provide a Target for the Treatment of Febrile Seizures , 2013, The Journal of Neuroscience.

[4]  A. Marson,et al.  Calcium antagonists as an add-on therapy for drug-resistant epilepsy. , 2013, The Cochrane database of systematic reviews.

[5]  J. Dreier,et al.  Delayed Cerebral Ischemia and Spreading Depolarization in Absence of Angiographic Vasospasm after Subarachnoid Hemorrhage , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  G. Yadav,et al.  Malignant Hyperthermia in Endosulfan Poisoning , 2012, Toxicology international.

[7]  Gregory C. Allen,et al.  Clinical Presentation, Treatment, and Complications of Malignant Hyperthermia in North America from 1987 to 2006 , 2010, Anesthesia and analgesia.

[8]  M. Denborough.  Malignant hyperthermia , 1998, The Lancet.

[9]  W. Hoffman,et al.  Improvement of brain electrical activity during treatment of porcine malignant hyperthermia with dantrolene. , 1993, British journal of anaesthesia.